Skip to main content
Boditech Med Inc. logo

Boditech Med Inc. — Investor Relations & Filings

Ticker · 206640 ISIN · KR7206640005 KO Manufacturing
Open in API
Filings indexed 243 across all filing types
Latest filing 2023-02-13 Earnings Release
Country KR South Korea
Listing KO 206640

About Boditech Med Inc.

https://www.boditech.co.kr/

Boditech Med Inc. is a company specializing in the development, manufacturing, and distribution of in-vitro diagnostic (IVD) solutions. The company focuses on key technologies in immunodiagnostics and molecular diagnostics to provide a range of diagnostic instruments and reagents. Its products are engineered to deliver reliable and accessible testing for various healthcare applications, from point-of-care to laboratory settings. The company's mission is to enhance the quality of life by providing advanced and dependable diagnostic tools to healthcare professionals worldwide.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Boditech Med. It provides a summary table of key financial metrics (revenue, operating profit, net income) for the 4th quarter of 2022. This is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q4 2022
2023-02-13 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Agreement' (신탁계약등에의한취득상황보고서) filed by Boditech Med Co., Ltd. to the Financial Supervisory Service (FSS) in South Korea. This document details the company's share buyback activities conducted through a trust agreement with Daishin Securities. In the context of financial filings, reports detailing the company's purchase or sale of its own shares (share repurchases) are classified as 'Transaction in Own Shares'.
2022-12-29 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) between Boditech Med and A. Menarini Diagnostics. It details the contract value, duration, and counterparty. Since this is a specific regulatory announcement of a commercial contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-12-23 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal regulatory notice of the record date. Given the nature of the announcement as a regulatory disclosure, it fits best under the RNS category.
2022-12-12 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Boditech Med regarding the setting of a record date for shareholder register closure to determine eligibility for potential cash dividends. While it mentions dividends, it explicitly states it is not the final dividend declaration, but rather a procedural step to establish the record date for future dividend distribution. This falls under the category of dividend-related announcements.
2022-12-12 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Boditech Med, Inc. covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial data, business operations, capital structure, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.